RETINA MACULA SPECIALISTS OF MIAMI LLC
NPI: 1982946612
· NORTH MIAMI BEACH, FL 33162
· 207W00000X
$914K
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
| 2018 |
14,768 |
$63K |
| 2019 |
20,735 |
$246K |
| 2020 |
15,354 |
$197K |
| 2021 |
17,626 |
$203K |
| 2022 |
13,317 |
$148K |
| 2023 |
13,618 |
$31K |
| 2024 |
7,042 |
$26K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Aflibercept injection |
3,442 |
2,095 |
$334K |
| 92012 |
|
7,485 |
4,413 |
$166K |
| 92134 |
|
14,523 |
8,773 |
$138K |
| 67028 |
|
12,997 |
7,293 |
$105K |
| 92014 |
|
3,265 |
2,121 |
$74K |
| 4177F |
|
3,975 |
2,806 |
$32K |
| 92250 |
|
3,098 |
1,802 |
$23K |
| 2022F |
|
2,182 |
1,617 |
$10K |
| G9903 |
Pt scrn tbco id as non user |
8,991 |
6,135 |
$7K |
| G9974 |
Mac exam perf |
3,892 |
2,606 |
$7K |
| J2778 |
Ranibizumab injection |
345 |
151 |
$6K |
| G8427 |
Docrev cur meds by elig clin |
8,044 |
5,955 |
$4K |
| J7999 |
Compounded drug, noc |
2,172 |
1,347 |
$2K |
| 92004 |
|
198 |
145 |
$2K |
| J9035 |
Bevacizumab injection |
363 |
317 |
$2K |
| 93886 |
|
235 |
148 |
$1K |
| J9999 |
Chemotherapy drug |
162 |
123 |
$577.90 |
| 93892 |
|
231 |
148 |
$533.85 |
| G9744 |
Pt not eli d/t act dig htn |
8,989 |
6,030 |
$234.55 |
| 1036F |
|
9,213 |
6,780 |
$90.76 |
| J3490 |
Drugs unclassified injection |
1,870 |
952 |
$41.60 |
| 93890 |
|
235 |
148 |
$23.07 |
| G8397 |
Dil macula/fundus exam/w doc |
809 |
605 |
$0.00 |
| G8428 |
Cur meds not document |
579 |
336 |
$0.00 |
| 92226 |
|
64 |
25 |
$0.00 |
| 2024F |
|
2,089 |
1,567 |
$0.00 |
| 2026F |
|
2,050 |
1,541 |
$0.00 |
| 92225 |
|
56 |
42 |
$0.00 |
| 5010F |
|
843 |
614 |
$0.00 |
| 76512 |
|
20 |
12 |
$0.00 |
| 0517F |
|
43 |
25 |
$0.00 |